Expanded treatment options, increased naloxone distribution and targeted education campaigns likely led to a 37% reduction in overdose deaths from opioids combined with stimulant drugs other than cocaine, according to the results of a large federally funded study.
AstraZeneca reports positive Phase III results for Imfinzi in small cell lung cancer – Pharmaceutical Technology
Share this article Imfinzi is approved in the US, EU, Japan, China, and other countries for the treatment of extensive-stage SCLC (ES-SCLC) based on results